Loading people...
David Topper is a Partner at Frazier Healthcare Partners based in Menlo Park, California, bringing over 35 years of financial experience to the firm. Prior to his transition into private equity, he spent more than a decade at J.P. Morgan as Vice Chairman and Co-Head of Global Equity Capital Markets, following a 22-year tenure at Morgan Stanley where he was Co-Head of US Equity Capital Markets. He later served as an Operating Partner at General Atlantic for seven years before joining Frazier to advise healthcare portfolio companies on financing and strategic acquisitions. In the life sciences sector, he acted as Chief Financial Officer for Frazier Lifesciences Acquisition Corporation, guiding its November 2022 merger with NewAmsterdam Pharma. He holds a bachelor's degree from Duke University and an MBA from the Stanford Graduate School of Business.
David Topper stands as a distinguished Partner at Frazier Healthcare Partners, a prominent private equity firm exclusively dedicated to the healthcare industry. In his pivotal role, Mr. Topper is responsible for sourcing, evaluating, and executing growth equity investments, contributing significantly to Frazier's mission of partnering with innovative healthcare companies to accelerate their growth and market leadership.
His investment focus at Frazier Healthcare Partners spans a broad spectrum of the healthcare landscape, including healthcare services, healthcare information technology, medical devices, and pharmaceutical services. David is particularly adept at identifying companies with strong management teams, proven business models, and significant growth potential, providing them with strategic capital and operational expertise to scale effectively. His approach emphasizes collaborative partnerships, working closely with portfolio company leadership to navigate market complexities and achieve strategic objectives.
Before joining Frazier Healthcare Partners in 2013, David Topper honed his expertise in growth equity investing at Summit Partners, a global alternative investment firm. During his tenure there, he gained valuable experience across various sectors, further solidifying his foundation in identifying high-growth opportunities. Prior to his career in private equity, Mr. Topper began his professional journey in investment banking at Morgan Stanley, where he developed a robust understanding of financial markets and corporate transactions. This diverse background provides him with a comprehensive perspective on investment strategies and value creation.
Throughout his career at Frazier, David Topper has been actively involved with numerous successful investments, often serving on the boards of directors for portfolio companies. While specific investment details are proprietary, his work has consistently focused on companies poised for significant expansion within their respective healthcare niches. His contributions have helped these companies enhance their market position, expand their services, and ultimately improve patient outcomes and healthcare efficiency. David's commitment to fostering innovation and growth within the healthcare ecosystem underscores his impact as a leader in the private equity space.
David Topper is a Partner at Frazier Healthcare Partners, a leading private equity firm focused exclusively on the healthcare sector. He specializes in growth equity investments, helping innovative healthcare companies expand and succeed.
David Topper primarily invests in growth equity opportunities within the healthcare industry. His focus areas include healthcare services, healthcare information technology, medical devices, and pharmaceutical services, seeking companies with strong growth potential.
David Topper works as a Partner at Frazier Healthcare Partners, a prominent private equity firm dedicated to making investments across the healthcare industry. He joined the firm in 2013.
